Granulocyte colony-stimulating factor (G-CSF) induces rapid phosphorylation of JAK kinases as well as activation of the p2lras route through interaction with its specific receptor (G-CSF-RI. The cytoplasmic membrane-proximal region of G-CSF-R (amino acids 631 to 684) is necessary for proliferation induction and activation of JAW. In contrast, activation of Shc and Syp, signaling molecules implicated in the p2lras signaling route, depends on the phosphorylation of tyrosine residues located in the membrane-distal region (amino acids 685 to 813) of G-CSF-R. We investigated whether G-CSFinduced activation of signaling complexes of the p2lras route depends on the function of the membrane-proximal cytoplasmic region of G-CSF-R. A G-CSF-R mutant was con-RANULOCYTE colony-stimulating factor (G-CSF) regulates the proliferation, differentiation, and survival of myeloid progenitor cells.' The diverse biologic effects of G-CSF are mediated through binding of G-CSF to a specific receptor (G-CSF-R) that belongs to the hematopoietin receptor superfamily.2,' The cytoplasmic domains of these receptors have no intrinsic kinase function and show very little overall sequence homology. The membrane-proximal cytoplasmic region of several members of this receptor superfamily, including G-CSF-R, contains two distinct subdomains designated as box 1 and box 2. This region is indispensable for transduction of mitogenic For most cytokine receptors it has now been shown that they activate cytoplasmic tyrosine kinases of the Janus kinase (JAK) family. Activation of JAK kinases is mediated via the membrane-proximal cytoplasmic region of the receptor. Subsequently, JAKs phosphorylate STAT (signal transducer and activator of transcription) proteins, which form homodimers and/or heterodimers, translocate to the nucleus, and activate target genes by interaction with specific DNA sequence^.'^'^ For erythropoietin receptor (EPO-R), interleukin-6 (IL-6) and IL-l1 signal transducer gpl30, and the common ,&chain of granulocyte-macrophage colony-stimulating The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.
RANULOCYTE colony-stimulating factor (G-CSF)
regulates the proliferation, differentiation, and survival of myeloid progenitor cells.' The diverse biologic effects of G-CSF are mediated through binding of G-CSF to a specific receptor (G-CSF-R) that belongs to the hematopoietin receptor superfamily.2,' The cytoplasmic domains of these receptors have no intrinsic kinase function and show very little overall sequence homology. The membrane-proximal cytoplasmic region of several members of this receptor superfamily, including G-CSF-R, contains two distinct subdomains designated as box 1 and box 2. This region is indispensable for transduction of mitogenic For most cytokine receptors it has now been shown that they activate cytoplasmic tyrosine kinases of the Janus kinase (JAK) family. Activation of JAK kinases is mediated via the membrane-proximal cytoplasmic region of the receptor. Subsequently, JAKs phosphorylate STAT (signal transducer and activator of transcription) proteins, which form homodimers and/or heterodimers, translocate to the nucleus, and activate target genes by interaction with specific DNA sequence^.'^'^ For erythropoietin receptor (EPO-R), interleukin-6 (IL-6) and IL-l1 signal transducer gpl30, and the common ,&chain of granulocyte-macrophage colony-stimulating factor receptor (GM-CSF-R), IL-3-R, and IL-5-R (pc), it The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact. been shown that the cytoplasmic membrane-proximal region of the receptor physically interacts with the JAK proteins.l3-IS Mutational analysis of EPO-R showed that a tryptophan residue (W282) located between box 1 and box 2 is essential for JAK2 activation and proliferative signaling of EPO-R." This tryptophan (Trp) is conserved in several proteins of the cytokine receptor superfamily, eg, IL-2-R pchain, IL-4-R, G-CSF-R, gp130, and p,. The essential role of JAK2 activation in mitogenesis was recently established using a kinase-deficient form of JAK2 in an EPO-dependent cell line."
The cytoplasmic domain of G-CSF-R contains four conserved tyrosines, all located in the membrane-distal region. Upon phosphorylation, these tyrosine residues form potential binding sites for signaling molecules that contain SH2 domains. Previously, it has been shown that, like IL-3 and EPO, G-CSF activates p2lras, MAP kinase, and a variety of SH2-containing signaling intermediates of the p2 Iras/MAP kinase route, eg, Shc and the phosphotyrosine phosphatase Syp (PTPID).lX'*' This occurs via the membrane-distal cytoplasmic region of G-CSF-R.IX It has not been established whether phosphorylation of these substrates depends on the integrity of box l/box2 region, implicated in the activation of JAK2.I"
In the present study, we have investigated the functional consequences of a single amino acid substitution (W650R), changing a Trp to an arginine (Arg) in the membrane-proximal cytoplasmic region of G-CSF-R. We show that this mutation completely abolishes the mitogenic response to G-CSF. No JAK2 phosphorylation and subsequent formation of STAT complexes could be detected on activation of the W650R mutant. Significantly, the ability of G-CSF-R to induce formation of pl45/Shc/Grb2, p90/Grb2, and Syp/Grb2 complexes is also completely abrogated by the W650R substitution. Thus, we show that the membrane-proximal cytoplasmic region of G-CSF-R is not only crucial for G-CSF-R-mediated signaling via the JAWSTAT pathway, but also for activation of signaling complexes of the p2lrds route, which occurs via the carboxy-terminal region of G-CSF-R. 
MATERIALS AND METHODS
(Pharmacia LKB, Uppsala, Sweden) were added for 1 hour at 4°C.
G-CSF-R expression constructs.
Human G-CSF-R cDNA was cloned in the pBluescript (pBS) vector and in the eukaryotic expression vector PLNCX.~ G-CSF-R mutation W650R was obtained by polymerase chain reaction (PCR)-mediated site-directed mutagenesis, as described previously.'* Human G-CSF-R cDNA cloned in pBS was used in the first PCR reaction as the template with the oligonucleotide 5' GGGCTCCCGGGTACCCACAATCAT 3' as the mutagenic primer (altered bases are uKderlined) together with the primer M13-20 (5' GTAAAACGACGGCCAGT 3'). a primer specific for pBS. In the second PCR, human G-CSF-R cDNA cloned in pLNCX was used as the template with the product of the first PCR as a megaprimer and with primers Ml3-20 and FR2 (5' TGT-GATCATCGTGACTCCCTT 3'). The PCR product was gel-purified and inserted into pLNCX. DNA sequencing was performed to confirm the presence of the introduced mutation and the integrity of the insert.
Cells and DNA transfection. The IL-3-dependent murine pro-B-cell line BAF3 was maintained in RPM1 1640 medium supplemented with 10% fetal calf serum (FCS) and murine L -3 (10 ng/ mL)." T h e pLNCX expression constructs were linearized by Pvu I digestion and transfected into BAF3 cells by electroporation. After gene transfer, neomycin-resistant clones were selected in IL-3-containing medium supplemented with 1.5 mg/mL G418 (GIBCO-BRL, Breda, The Netherlands) and expanded for further analysis. To determine G-CSF-R expression levels, cells were treated with rabbit antiserum against the extracellular domain of human G-CSF-R and fluorescein isothiocyanate-labeled goat antirabbit IgG (GAR/FITC; Nordic Immunology, Tilburg, The Netherlands) and analyzed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA). To estimate the affinities of the G-CSF binding sites, '*'I-G-CSF binding experiments and Scatchard analysis were performed as described.' DNA synthesis assay. DNA synthesis was assessed by ['HIthymidine ('H-TdR) uptake. Cells (lo4) were incubated in triplicate in 1 0 0 pL of 10% FCS-RPM1 medium supplemented with titrated concentrations of human G-CSF or with 10 ng/mL murine L -3 in 96-wells plates for 48 hours. Sixteen hours before cell harvest, 0.1 pCi of 'H-TdR (2 Ci/mmoVL; Amersham International, Amersham, UK) was added to each well. 3H-TdR incorporation was measured by liquid scintillation counting.
Immunoprecipitation and Western blotting. Cells (2 X 10') were deprived of serum and growth factors for 4 hours at 37°C. One hour before the addition of growth factors, 10 pmol/L Na3V04 was added. Cells were incubated for 10 minutes at 37°C in the presence of G-CSF (100 ng/mL) or IL-3 (1 pg/mL) or without factor. The reaction was terminated with ice-cold phosphate-buffered saline. Cells were lysed by incubation for 30 minutes at 4°C in lysis buffer. Insoluble materials were removed by centrifugation for 15 minutes at 10,OOOg at 4°C. For JAK2 immunoprecipitations, a lysis buffer was used that contained 50 mmol/L Tris (pH 8.0), 50 mmol/L NaF, 200 mmol/L NaCI, 10% glycerol, 0.5% (voUvol) Triton X-100, 0.1 mmol/L Na,V04, and 1 mmol/L Pefabloc SC, 50 pg/mL aprotinin, 50 pg/ mL leupeptin, 50 pg/mL bacitracin, and 50 pg/mL iodoacetamide as protease inhibitors. For Shc and Grb2 immunoprecipitations, we used a lysis buffer containing 20 mmom Tris (pH 8.0), 137 mmoU L NaCI, 10 mmoVL EDTA, 100 mmol/L NaF, 1% Nonidet P-40, 1 mmol/L DTT, 10% glycerol, 2 mmol/L Na3V04, and the cocktail of protease inhibitors. Cell lysates were incubated overnight at 4°C with rabbit polyclonal anti-JAK2 antiserum (kindly provided by Dr J.N. Ihle, Memphis, TN), anti-Grb2 (Santa Cruz Biotechnology Inc, Santa Cmz, CA), or anti-Shc (kindly provided by Dr J.L. BOS, Utrecht, The Netherlands) antibodies. Protein A-Sepharose beads After five washings in lysis buffer, proteins were eluted from the beads by boiling in sodium dodecyl sulfate (SDS)-sample buffer, subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE), and electrotransferred onto nitrocellulose (Schleicher & Schuell, Dassel, Germany). Filters were blocked by incubation in 0.3% Tween-20 in Tris-buffered saline (TBS; 10 mmom Tris [pH 7.41, 150 mmol/L NaCI) for 1 hour at 37"C, washed in TBS containing 0.05% Tween-20 (TBS-T), and incubated with various antibodies. The antibodies used for Western blotting were antiphosphotyrosine antibody 4G10 (Upstate Biotechnology Inc. Lake Placid, NY), antiShc, anti-Grb2, anti-JAK2, and anti-Syp (Santa Cruz). After five washings in TBS-T, the filters were probed with horseradish peroxidase-conjugated species specific antiserum (DAKO A / S , Glostrup, Denmark), followed by enhanced chemiluminescence reaction (DuPont, Boston, MA). For reprobing with different antibodies, blots were stripped in 62.5 mmol/L Tris-HC1 (pH 6.7); 2% SDS, and 100 mmom P-mercaptoethanol at 50°C for 30 minutes and reblocked with 0.3% Tween-20 in TBS.
Gel retardation assays. Nuclei of 2 X lo6 cells were obtained by lysis in a hypotonic buffer (20 mmol/L HEPES [pH 7.81, 20 mmom NaF, 1 mmoVL Na3V04, 1 mmol/L N%PZO7, 1 mmol/L D m , 1 mmol/L EDTA, 1 mmol/L EGTA, 0.2% Nonidet P-40,0.125 pmoVL okadaic acid, and the cocktail of protease inhibitors). After lysis of the cells, nuclei were precipitated by centrifugation at 15,000g for 30 seconds. Nuclear extracts were prepared using a high-salt buffer (hypotonic buffer with 420 mmol/L NaCl and 20% glycerol). Insoluble materials were removed by centrifugation for 20 minutes at 20,000g at 4°C. The extracts were incubated at room temperature for 20 minutes with 0.2 ng of "P-labeled doublestranded STAT-binding oligonucleotide and 2 pg of poly(d1-dC) in binding buffer (13 mmol/L HEPES [pH7.8], 80 mmoVL NaC1, 3 mmol/L NaF, 3 mmol/L NaMo04, 1 mmoVL DlT, 0.15 mmol/L EDTA, 0.15 mmoVL EGTA, 8% glycerol).z3 The oligonucleotide used was m67 (5' CATlTCCCGTAAATC 3').24 DNA-protein complexes were separated on 5% nondenaturing polyacrylamide gels in 0.25X TBE and visualized by autoradiography.
RESULTS

Expression of wild-type and mutant G-CSF-R in BAF3
transfectants. Expression of wild-type (WT) and mutant (W650R) G-CSF-R proteins in BAF3 transfectants was first examined by FACScan analysis using G-CSF-R antibodies (Fig 1) . Two representative BAF/W650R clones (12.1 and G-CSF fails to induce proliferation of BAFM65OR transfectants. Expression of WT G-CSF-R in BAF3 cells confers G-CSF-dependent proliferation. The ability of G-CSF to induce proliferative signals in BAF/W650R cells was examined by 3H-TdR uptake assays (Fig 2) . BAFNT clones responded to G-CSF in a dose-dependent manner, with a maximal response at 3 ng/mL G-CSF. In contrast, BAF/ W650R transfectants did not respond to G-CSF, even at high concentrations of G-CSF (3.3 pg/mL). Four independent W650R clones gave identical results. In contrast to BAF/WT cells that proliferate and can be maintained in the presence of 
G-CSF as the single growth factor, BAF/W650R cells died within 24 hours in G-CSF-supplemented medium (data not shown).
G-CSF fails to activate JAK2 and STATs in BAFN45OR cells. G-CSF induced tyrosine phosphorylation of JAK2 in BAF/WT cells (Fig 3) . In contrast, G-CSF failed to activate JAK2 in BAF/W650R transfectants. In parallel control incu- bations, L 3 induced tyrosine phosphorylation of JAK2 in both BAF/WT and BAF/W650R transfectants. Gel retardation assays with STAT binding m67 oligonucleotides showed that three STAT complexes are formed in BAF/WT cells treated with G-CSF (Fig 4) . These three complexes consist of STATl homodimers, STATUSTAT3 heterodimers, and STAT3 homodimers." In contrast, G-CSF failed to induce STATl and/or STAT3 DNA binding in BAFI W650R cells, whereas E -3 did.
G-CSF also fails to activate Shc, Grb2, and Syp containing complexes in BAFN65OR cells. Shc immunoprecipitates from G-CSF-stimulated BAF/WT cells contained tyrosine-phosphorylated Shc and p145 (Fig 5) . In contrast, no activation of Shc and p145 was seen after G-CSF stimulation in BAF/W650R transfectants, despite the equal presence of Shc proteins as compared with BAF/WT cells. L 3 induced phosphorylation of Shc and p145 in all of these transfectants. After incubation of BAF/WT cells with G-CSF and IL-3, tyrosine-phosphorylated Shc, Syp, p90, and p145 coprecipitated with Grb2 (Fig 6) . G-CSF stimulation of BAF/ W650R transfectants did not induce association of Grb2 with phosphorylated Shc, Syp, p90, or p145, whereas, in parallel control incubations, IL-3 did induce the formation of these complexes (Fig 6) .
DISCUSSION
In previous investigations, distinct functional regions in the cytoplasmic domain of G-CSF-R have been identified.s~6*zs It was found that the membrane-distal region of approximal 100 amino acids is required for the induction of neutrophilic maturation, whereas a membrane-proximal region of 55 amino acids is essential for mitogenic signaling.
For (-1, with G-CSF (100 ng/mL), or with IL-3 (l pg/mL) This latter region contains the box 1 and 2 sequences conserved among several members of the hematopoietin receptor superfamily. Site-directed mutagenesis of G-CSF-R confirmed the importance of box 1 in proliferative signaling of G-CSF. Replacement of Pro-638 and Pro-640 of human G-CSF-R and replacement of Trp-634, Pro-638, and Pro-640 and Asp-639 located within box 1 of murine G-CSF-R completely inactivated G-CSF-induced mitogenesis.'.*" The mechanism by which these substitutions result in the inactivation of the receptor is not known.
The present study was initiated to determine the importance of Trp-650 of G-CSF-R, positioned between box 1 and box2, for signal transduction. We have shown that substitution of Arg for Trp at this position completely abolishes the mitogenic signaling abilities of G-CSF-R as well as its capacity to induce JAK2 phosphorylation. Binding studies with '"I-G-CSF showed that mutant W650R had a similar affinity for the ligand, indicating that the loss of G-CSF responsiveness cannot be explained by a loss of G-CSF binding to mutant W650R-receptor.
Studies on the EPO-R have shown that JAK2 physically associates with the membrane-proximal domain of the receptor.I3 In analogy with the observations in EPO-R, in which a similar amino acid substitution (W282R), completely inactivates proliferative signaling by EPO-R and disrupts the interaction between JAK2 and EPO-R,16 we assume that mutant W650R fails to bind JAK2. The exact mechanism of JAK association to G-CSF-R is not yet clear. JAK kinases do not contain SH2 or SH3 domains, motifs that are essential for the interaction of a variety of cytoplasmic protein tyro- sine kinases with receptor molecules. In EPO-R, box I as well as the region between box 1 and 2 are required for binding of JAK2.I3 Similarly, JAK2 binding to the common &chain of GM-CSF-R, IL-3-R, and IL-S-R requires the box 1 region and the downstream 14 amino acids, which include the conserved Trp residue." In contrast, in prolactin receptor, also a member of the cytokine receptor superfamily, box 1 is sufficient for JAK2 activation. In this receptor, a deletion immediately C-terminal of box 1 has no effect on the interaction with JAK2.27 Notably, prolactin receptor does not contain the conserved Trp. Therefore, it is possible that association of JAK2 with different receptors involves distinct amino acid residues in addition to box 1.
Recent findings in our laboratory have shown that a G-CSF-R mutant 6685-813 (MI), that lacks all four cytoplasmic tyrosine residues, is unable to activate Shc and Syp." Many growth factors induce phosphorylation of Shc, sequentially resulting in formation of the Shc/Grb2/Sos complex, p2lras-GTP formation, and cellular responses. It has been shown that tyrosine 764 of G-CSF-R is essential for G-CSF-induced Shc phosphorylation and its association to p145 and Grb2.I' Syp, like Shc, can link Grb2 to receptor proteins, thereby providing a mechanism for activation of p21ras. For instance, Syp couples Grb2 to phosphorylated tyrosine 1009 of PDGF-R," a tyrosine involved in PDGFinduced activation of the p2lras route.29
Results from the present study and our previous findings" fit into the following model. Upon G-CSF binding, wildtype G-CSF-R activates JAK2, which subsequently phosphorylates the tyrosine residues within the C-terminal region of the receptor. These phosphotyrosines then form binding sites for the SHZcontaining signaling molecules involved in the p2lras route, such as Shc and Syp. Mutant W650R fails to bind and activate JAK2. Consequently, the cytoplasmic tyrosines of G-CSF-R will not be phosphorylated and thereby cannot recruit pl45/Shc/Grb2, p9OlGrb2, or Sypl Grb2 complexes to the receptor.
Although this and other ~tudies'~.'' strongly suggest that JAK kinases are crucial for proliferative signaling of hematopoietin receptors and that activation of JAKs is required for activation of p2lras route, it is still not completely clear to what extent the JAWSTAT and p2lras signaling pathways converge and contribute to the distinct cellular responses 
IP: aGRB2
induced via G-CSF-R. Recently, expression of a dominant inhibitory mutant of c-Ha-ras in 32Dc13 cells was found to interfere with IL-3-induced proliferation."" In contrast, G-CSF could still induce neutrophilic maturation in these cells, suggesting that activation of the p2lras pathway per se is not required for maturation induction."" Extension of these investigations, for instance with the use of G-CSF-responsive 32D cell transfectants in which both JAK and p2lras function can be sequentially or simultaneously altered by dominant negative mutants, may help to further elucidate the complex interplay between JAWSTAT and p2lras signaling pathways in G-CSF-R-mediated proliferation, maturation, and survival of myeloid precursor cells. 
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